Evidence map›Paper›PMID 41999285›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Challenges in Malaria Diagnosis and Treatment in Kinshasa Province, Democratic Republic of the Congo.

Ruthly François-Zafka, Daniel Westreich, Kristin Banek, Melchior Mwandagalirwa Kashamuka, Sam J White, Joseph A Bala, Marthe Nkalani, Georges Kihuma, Joseph Atibu, Georges E Mahilu and 7 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ruthly François-ZafkaDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0009-0007-4660-196X
Daniel WestreichDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0003-3069-1650
Kristin BanekDepartment of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.ORCID 0000-0001-9219-2852
Melchior Mwandagalirwa KashamukaDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Sam J WhiteInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0009-0006-1351-1020
Joseph A BalaDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0009-0004-0789-928X
Marthe NkalaniDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0009-0001-1689-0015
Georges KihumaDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0009-0003-9438-4630
Joseph AtibuDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Georges E MahiluDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0009-0007-2673-7229
Kyaw L ThwaiInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jack KokolomamiDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Michael EmchDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jessie EdwardsDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-1741-335X
Jonathan J JulianoDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-0591-0850
Antoinette TshefuDepartment of Epidemiology and Biostatistics, Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0000-0001-7657-6901
Jonathan B ParrInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-4465-9830

Funding

Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of AlternativesR01AI132547 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DINGLASAN, RHOEL DAVID RAMOS, JULIANO, JONATHAN J · 2018 to 2022
$3.6M
Epidemiological and Spatial Models of Malaria TransmissionR01AI107949 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MESHNICK, STEVEN RICHARD · 2014 to 2018
$2.5M
Mentoring in Translational Malaria GenomicsK24AI134990 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan J Juliano · 2018 to 2026
$1.6M
A longitudinal epidemiological and epidemiological study of malaria and its vectors in the Kinshasa provinceR01AI129812 · NIAID · KINSHASA SCHOOL OF PUBLIC HEALTH · PI TSHEFU, ANTOINETTE KITOTO · 2017 to 2021
$674k
Characterization of the antimalarial drug resistance landscape in Kinshasa Province, Democratic Republic of the CongoF30AI179110 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ruthly Francois · 2024 to 2026
$134k
Gates Foundation INV-050353National Health Institutes D43009340National Health Institutes F30AI179110National Health Institutes K24AI134990National Health Institutes R01AI107949National Health Institutes R01AI129812National Health Institutes R01AI132547National Health Institutes T32AI070114NIAID NIH HHS F30 AI179110NIAID NIH HHS K24 AI134990NIAID NIH HHS R01 AI107949NIAID NIH HHS R01 AI129812NIAID NIH HHS R01 AI132547NIAID NIH HHS T32 AI070114
6 · The paper itself

Abstract

backgroundEffective malaria case management relies on accurate diagnosis and appropriate treatment. However, rapid diagnostic test (RDT) performance varies, and presumptive treatment remains common. We quantified malaria misdiagnosis and inappropriate treatment and assessed adherence to treatment guidelines in a high-burden setting.

methodsWe leveraged samples collected during a cohort study of children and adults from 2015 to 2022 across 7 sites in Kinshasa Province, Democratic Republic of the Congo (DRC). We estimated the cumulative incidence and prevalence of false-positive and false-negative RDT results using polymerase chain reaction (PCR) as the gold standard and identified correlates of misdiagnosis and inappropriate treatment using Kaplan-Meier and generalized estimating equations.

resultsAmong 2269 participants, the 1-year cumulative incidences of false-positive and false-negative RDTs were 23.1% and 17.8%, respectively; by 7 years, these rose to 77.7% and 83.4%. Misdiagnosis (false-positive or false-negative RDT) was associated with age, recent treatment, transmission intensity, and parasite density-factors that could inform refinements to treatment guidelines. About 58% of RDT-negative participants received antimalarial treatment at a clinic visit, while 4% of RDT-positive participants did not. Fever significantly reduced adherence to test-and-treat guidelines.

conclusionsMost participants experienced malaria misdiagnosis by RDT over the course of the study, underscoring the limitations of currently used RDTs and opportunities for improved clinical decision-making. While RDTs remain essential for malaria case management, clinicians should consider contextual factors when interpreting results. Efforts to improve adherence to guidelines, which require a positive diagnostic test result before treatment, and management of non-malarial febrile illness are needed in the DRC and similar high-burden settings.

Indexed as

Diagnostic ErrorsMalariaAdolescentAdultAntimalarialsChildChild, PreschoolCohort StudiesDemocratic Republic of the CongoFalse Positive ReactionsFemaleHumansIncidenceInfantMalaria, FalciparumMaleAntimalarialsdiagnosisDRCmalariaPlasmodium falciparumtreatment

Identifiers

PMID41999285
PMCPMC13393125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.